Skip to content
OpenCapital
Get started

Organon OGN Free cash flow margin

Free cash flow margin at other companies

Pfizer logo
PfizerPFE
18%+8.8pp
Amgen logo
AmgenAMGN
23.1%-8.9pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
13.5%+4.3pp
Biogen logo
BiogenBIIB
24.4%-0.4pp
AbbVie logo
AbbVieABBV
31.8%+5.0pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
7.9%-1.0pp

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Calculated from Organon’s reported figures.

free cash flow/total revenue=11.1%

Based on trailing twelve months.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's free cash flow margin?
Organon (OGN) reported free cash flow margin of 11.1% in Q1 2026.
How has Organon's free cash flow margin changed year-over-year?
Organon's free cash flow margin decreased by 10.2% year-over-year, from 12.3% to 11.1%.
What is the long-term trend for Organon's free cash flow margin?
Over 5 years (2020 to 2025), Organon's free cash flow margin has grown at a -22.6% compound annual growth rate (CAGR), from 31.1% to 8.7%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.